Thomas W. Burns - 15 Dec 2022 Form 4 Insider Report for GLAUKOS Corp (GKOS)

Role: CHAIRMAN & CEO, Director
Signature: Diana Scherer, Attorney-in-Fact
Issuer symbol: GKOS
Transactions as of: 15 Dec 2022
Net transactions value: $0
Form type: 4
Filing time: 19 Dec 2022, 18:45:53 UTC
Previous filing: 05 Dec 2022
Next filing: 13 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GKOS	Common Stock	Award	$0	+10,420	+1.5%	$0.000000	684,705	15 Dec 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GKOS	Stock Option (Right to Buy)	Award	$0	+21,039		$0.000000	21,039	15 Dec 2022	Common Stock	21,039	$55.18	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on December 15, 2022 that certain of the operational targets had been achieved. The number of shares of common stock reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. 70% of the number of shares of common stock reported herein will vest and be delivered in January 2023, and the remaining 30% will vest and be delivered in March 2023.
F2	Includes 91,279 restricted stock units that have not yet vested or been delivered to the Reporting Person.
F3	Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation Committee determined on December 15, 2022 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.
F4	70% of the portion of the option reported herein will vest and become exercisable in January 2023, and the remaining 30% will vest and become exercisable in March 2023.